Fintel reports that on November 15, 2024, B of A Securities downgraded their outlook for bluebird bio (MUN:BLE) from Buy to Neutral. As of December 21, 2023, the average one-year price target for ...

Fintel reports that on August 15, 2024, JP Morgan downgraded their outlook for bluebird bio (MUN:BLE) from Overweight to Neutral. As of December 21, 2023, the average one-year price target for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

bluebird bio Inc. Annual cash flow by MarketWatch. View BLE net cash flow, operating cash flow, operating expenses and cash dividends.